SGO Issues Dec. 14, 2017
Pilot SGO COR program placed on hiatus
December 2017 Gynecologic Oncology focuses on fertility sparing
SGO announces Membership Department staff changes
Late-breaking abstracts open until Jan. 17
After careful assessment of the clinical and financial viability of the SGO Clinical Outcomes Registry (COR), last month the SGO Board of Directors decided to place SGO COR on hiatus. Effective Jan. 1, 2018, no new patient records will be accepted. Participating sites may continue to add follow-up patient data for existing patient records through the end of 2018. In 2019, the COR will no longer accept patient data. SGO will continue to explore collaborative gynecologic oncology registry opportunities with partners possessing adequate resources and infrastructure.
Since it was founded in 2013, over 6,700 patient records have been accrued from approximately 29 sites.
“This effort has demonstrated the ability to develop an in-depth gynecologic oncology registry with long-term outcome capability that is usable for quality reporting and outcomes research,” said SGO President Laurel W. Rice, MD.
“At the same time, the SGO COR has faced a number of challenges, including manual data entry, variability of personal entering the data, and ability to adapt to the need for updating data fields including changes in clinical knowledge, therapy and quality outcome regulatory priorities,” said Dr. Rice. “Perhaps most significantly, financial support for the COR has yet to exceed expenses.”
Although SGO will no longer be maintaining the registry, Dr. Rice said that the SGO Board considers SGO COR to be a successful pilot program. By using the data collected on patients with cervical, endometrial or ovarian cancer, quality initiatives were developed and the data is under review for potential research projects. COR participants who have questions about the transition period may contact Amy Dancisak, email@example.com, at 312-676-3907.
- Fertility-preserving surgery for advanced stage ovarian germ cell tumors Dimitrios Nasioudis, Melissa K. Frey, Eloise Chapman-Davis, Thomas A. Caputo, Kevin Holcomb
- Factors influencing fertility-sparing treatment for gynecologic malignancies: A survey of Society of Gynecologic Oncology members Jaimin S. Shah, Rosa Guerra, Diane C. Bodurka, Charlotte C. Sun, Gary B. Chisholm, Terri L. Woodard
- A call to standardize our approach to fertility-sparing surgery in patients with gynecologic cancers Emeline M. Aviki, Nadeem R. Abu-Rustum
ALL IN VIDEO
SGO is pleased to announce two new staff changes:
Eva Lopez-Flores has accepted the position of Membership Manager. She joined SGO in October 2014 and previously served as the Senior Membership Coordinator.
Amy Dancisak has accepted the position of Senior Membership Coordinator. Amy joined SGO’s staff in June 2014 and was previously the Senior Manager of Quality and Outcomes managing the SGO Clinical Outcomes Registry.
SGO encourages all medical professionals who are part of the women’s cancer care team to submit late-breaking abstracts for consideration in the 2018 SGO Annual Meeting on Women’s Cancer final scientific program. The late-breaking abstract session will highlight data of the highest scientific impact that has become available since the original 2018 Annual Meeting abstract submission deadline. Late-breaking abstracts will be accepted through Wednesday, Jan. 17, 11:59 p.m. Central Standard Time. Submit abstracts online and review the abstract guidelines prior to submission. Accepted science will be announced in late February.